Want to see JP:9301 full AI Analyst Report?
Mitsubishi Logistics (9301) Drug Pipeline
| Drug Name | Condition | Stage | Status | Study Name | Trial Start Date | Article |
|---|---|---|---|---|---|---|
| Macitentan 10 Mg | Chronic Thromboembolic Pulmonary Hypertension (Cteph) | Phase III | Terminated | A Clinical Study to Find Out if Macitentan is Effective and Safe in Japanese Patients With Chronic Thromboembolic Pulmonary Hypertension (CTEPH). | Jan 10, 2019 | ― |
| Drug Name | Stage | Condition | Status | Study Name | Trial Start Date | Article |
|---|---|---|---|---|---|---|
| Macitentan 10 Mg | Phase III | Chronic Thromboembolic Pulmonary Hypertension (Cteph) | Terminated | A Clinical Study to Find Out if Macitentan is Effective and Safe in Japanese Patients With Chronic Thromboembolic Pulmonary Hypertension (CTEPH). | Jan 10, 2019 | ― |
FAQ
What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases: a. Preclinical testing b. Phase 1 – Safety and dosage c. Phase 2 – Effectiveness and side effects d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Mitsubishi Logistics Corporation (JP:9301) have in its pipeline
Mitsubishi Logistics JP:9301 is currently developing the following drugs: Macitentan 10 Mg. These drug candidates are in various stages of clinical development as the company works toward FDA approval.